Houde VP, Brl S, Festuccia WT, Blanchard PG, Bellmann K, Deshaies Y, Marette A (2010) Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue
Anisimov VN, Khavinson VK, Provinciali M, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Imyanitov EN, Mancini R, Franceschi C
Nishikawa, M., Tamada, A., Kumai, H., Yamashita, F
Why Choose IV Glutathione Treatment
In AD mice, treatment with this hydrogel reduced epidermal thickness, decreased 8-OHdG accumulation, lowered Th2 cytokine and IgE levels, and reduced mast cell infiltration, showing its therapeutic potential for AD management (204)
These results have not been replicated in human clinical trials, so it is unclear whether these effects translate to human patients